Summary
This Global Burden of Disease 2023 study synthesises epidemiological data on chronic respiratory diseases across 195 countries and territories from 1990 to 2023, explicitly quantifying COVID-19's impact on respiratory disease burden. The analysis provides updated estimates of disease prevalence, mortality, and disability stratified by region and nation, alongside trend analysis over three decades. These comprehensive estimates are intended to inform respiratory health policy prioritisation and resource allocation globally.
Regional applicability
As a global burden study, findings are directly applicable to United Kingdom epidemiological assessment and health policy planning for respiratory diseases. The study will provide UK-specific burden estimates comparable to international benchmarks, though local application depends on integrating findings with NHS service planning and capacity data.
Key measures
Disease prevalence, mortality rates, disability-adjusted life years (DALYs), years of life lost (YLL), and years lived with disability (YLD) stratified by region, nation, age, and sex; temporal trends 1990–2023
Outcomes reported
Synthesised epidemiological estimates of prevalence, mortality, and disability burden from chronic respiratory diseases across 195 countries and territories from 1990 to 2023, with explicit quantification of COVID-19 pandemic impact on respiratory disease burden.
Topic tags
Dig deeper with Pulse AI.
Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.